Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of metastatic uveal melanoma
Economic impact of diagnostic testing
8 evidence topics · 9 sources
Payment rates for HLA class I typing and uveal melanoma gene expression profiling on a 2026 state Medicaid laboratory fee schedule
| Test | Code | Description | Rate |
|---|---|---|---|
| HLA class I typing, high resolution, one locus | “81380” | “HLA CLASS I TYPING HIGH RESOLUTION ONE LOCUS” | “$177.25” |
| HLA class I typing, high resolution, one allele or allele group | “81381” | “HLA CLASS I TYPING HIGH RESOLUTION ONE ALLELE OR ALLELE GROUP” | “$169.90” |
| Gene expression profiling of uveal melanoma, 15 genes | “81552” | “MRNA GENE EXPRESSION ANALYSIS OF 15 GENES IN EYE MELANOMA O TISSUE OR FINE NEEDLE ASPIRATE” | “$7,776.00” |
HLA-A∗02:01 test at a U.S. reference laboratory: billing code, method, specimen, and turnaround
| Item | Labcorp test 167107, HLA A A∗02:01-Specific |
|---|---|
| CPT code | “81381” |
| Methodology | “Next Generation Sequencing (NGS), sequence-based typing (SBT) or other DNA methods as needed to achieve desired resolution” |
| Result turnaround time | “3 - 7 days” |
| Specimen | “Whole blood, buccal swabs, spot cards or extracted DNA” |
| Regulatory status | “This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.” |
HLA-A∗02:01 status recorded in a U.S. real-world cohort
Medicare coverage of gene expression profiling of the primary tumor
Medicare payment rate and annual volume of the DecisionDx-UM test
Biopsy, prognostic genetic testing, and out-of-pocket payment reported in a Canadian patient and caregiver survey
Surveillance intensity by metastatic risk class and modeled reduction in surveillance procedures
Liver surveillance imaging volume and modeled savings from risk-based screening in the United Kingdom
“A total of 3854 liver scans were performed on the 615 patients, with a median of 6.2 scans per patient (range, 1–40). Liver MRI was the most performed modality, 2419 scans (63%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Results showed that at 80% sensitivity, 87% of UM patients will avoid unnecessary radiological scans. This provides potential cost savings of between £46,000 and £97,000 per year to the National Health Service assuming 600 new cases per year.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote